TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial.
Cwynarski K, Iacoboni G, Tholouli E, Menne T, Irvine DA, Balasubramaniam N, Wood L, Shang J, Xue E, Zhang Y, Basilico S, Neves M, Raymond M, Scott I, El-Kholy M, Jha R, Dainton-Smith H, Hussain R, Day W, Ferrari M, Thomas S, Lilova K, Brugger W, Marafioti T, Lao-Sirieix P, Maciocia P, Pule M.
Cwynarski K, et al. Among authors: ferrari m.
Nat Med. 2024 Nov 11. doi: 10.1038/s41591-024-03326-7. Online ahead of print.
Nat Med. 2024.
PMID: 39528665